Concepedia

Alain Thibault

AT

36

Publications

3K

Citations

26

H-Index

1991

Active since

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Ablynx (Belgium)

University of Rochester

Institut Jules Bordet

Alain Thibault is an author at National Cancer Institute specializing in medicine, oncology, and pharmacology.

Top concepts

Publications per year

1991–2017

36

Publications

36

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

Judith E. Karp, Jeffrey E. Lancet, Scott H. Kaufmann et al. · Blood · 2001 · 445 citations · Full text

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

Alain Thibault, Dvorit Samid, A Tompkins et al. · PubMed · 1996 · 361 citations

, , +11

Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies

Jörge E. Cortes, Maher Albitar, Deborah A. Thomas et al. · Blood · 2003 · 209 citations

A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer.

Alain Thibault, Michael R. Cooper, William D. Figg et al. · PubMed · 1994 · 157 citations

, , +13

Phase II Study of R115777, a Farnesyl Transferase Inhibitor, in Myelodysplastic Syndrome

Razelle Kurzrock, Maher Albitar, Jörge E. Cortes et al. · Journal of Clinical Oncology · 2004 · 146 citations · Full text

Rows per page

1–5 of 36